CYP2D6: A key enzyme in morphine synthesis in animals

被引:0
|
作者
Zhu, Wei [1 ]
机构
[1] SUNY Coll Old Westbury, Neurosci Res Inst, Old Westbury, NY 11568 USA
来源
MEDICAL SCIENCE MONITOR | 2008年 / 14卷 / 11期
关键词
morphine; CYP2D6; nicotine; alcohol; mu3; opiate receptor;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Our laboratory and others have demonstrated that animals can make morphine, meaning its biosynthetic pathway has been conserved during evolution. Among the many enzymes involved in this process, CYP2D6 is of particular importance because of its role in multiple steps of morphine precursor metabolism, as well as its distribution in a variety of tissues, such as neuronal and immune. Additionally, its genetic variations support its role in this process. Elucidating its role in the critical metablic processes involved with many drugs, not just opiate alkaloids may provide a critical understanding of induced addiction, analgesia, immune-and vascular regulation. Its presence in invertebrate tissues underscores its singular significance in these processes as well, allowing one to hypothesize its role in actions of many substances of abuse.
引用
收藏
页码:SC15 / SC18
页数:4
相关论文
共 50 条
  • [21] Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants
    Zhong, Yun-shan
    Kong, Qi-hui
    Wang, Jing
    Ye, Feng
    Li, Xin-yue
    Zhang, Li-qun
    Dai, Da-peng
    Hu, Guo-xin
    Cai, Jian-ping
    Qian, Jian-chang
    Ji, Fu-sui
    CHEMICAL RESEARCH IN TOXICOLOGY, 2024, 37 (11) : 1903 - 1910
  • [22] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
    Shiran, Mohammad R.
    Soteh, Mohammad B. Hashemi
    Merat, Fatemeh
    Sarzare, Fatemeh
    Salehifar, Ebrahim
    DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261
  • [23] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation:: a study of mutations CYP2D6*3 and CYP2D6*4
    Monek, O
    Paintaud, G
    Bechtel, Y
    Miguet, JP
    Mantion, G
    Bechtel, PR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (01) : 47 - 52
  • [24] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation: a study of mutations CYP2D6*3 and CYP2D6*4
    O. Monek
    G. Paintaud
    Y. Bechtel
    J. P. Miguet
    G. Mantion
    P. R. Bechtel
    European Journal of Clinical Pharmacology, 1998, 54 : 47 - 52
  • [25] CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene
    Skierka, Jennifer M.
    Walker, Denise L.
    Peterson, Sandra E.
    O'Kane, Dennis J.
    Black, John Logan, III
    PHARMACOGENOMICS, 2012, 13 (08) : 951 - 954
  • [26] Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
    Charoenchokthavee, Wanaporn
    Panomvana, Duangchit
    Sriuranpong, Virote
    Areepium, Nutthada
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 149 - 155
  • [27] A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function
    Oscarson, M
    Hidestrand, M
    Johansson, I
    Ingelman-Sundberg, M
    MOLECULAR PHARMACOLOGY, 1997, 52 (06) : 1034 - 1040
  • [28] Induction of CYP2D6 in pregnancy
    Wadelius, M
    Darj, E
    Frenne, G
    Rane, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (04) : 400 - 407
  • [29] Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation
    Grobe, Nadja
    Kutchan, Toni M.
    Zenk, Meinhart H.
    FEBS LETTERS, 2012, 586 (13) : 1749 - 1753
  • [30] The interaction of terfenadine with CYP2D6
    Jones, BC
    Hyland, R
    Ackland, M
    Tyman, CA
    Smith, DA
    FASEB JOURNAL, 2000, 14 (08): : A1503 - A1503